FibroBiologics is a clinical-stage cell therapy company developing fibroblast-based treatments and potential cures for chronic autoimmune and degenerative diseases. Its pipeline targets conditions including multiple sclerosis, degenerative disc disease, osteoporosis, and burns using proprietary fibroblast cell and fibroblast-derived material technologies. The company is publicly traded on Nasdaq (FBLG) and operates a dedicated research and manufacturing laboratory in Houston, Texas.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2024
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
